Background: Nocardia are organisms that can escape the effects of both immune response and antimicrobial agents, due to their potential capacity to grow intracellularly. In previous studies, we found that experimental oxazolidinones, DA-7157 and DA-7218, are active both in vitro and in vivo.
Introduction
Mycetoma in Mexico is mainly caused by actinomycetes, the predominant species being Nocardia brasiliensis (86.6% of cases). 1 Clinical lesions evolve very slowly, but sometimes can grow extensively, affecting a whole limb. The medical treatment of this disease requires that antibiotics be administered for several months, and this sometimes leads to the emergence of resistance. 2 Trimethoprim/sulfamethoxazole is the drug of choice, as it achieves adequate concentrations in the affected tissues, including bones. The high failure rate of treatments, however, prompts the use of drug combinations as well as the search for new active molecules. Linezolid, a recently described oxazolidinone, has been used effectively in the therapy of patients with nocardiosis; 3 however, it is expensive, and side effects such as peripheral neuropathy and myelosuppression have been reported during long-term use in some patients. 4 New oxazolidinone compounds such as DA-7867 and DA-7218 (the DA-7157 pro-drug) have shown excellent activity both in vitro and in vivo against N. brasiliensis. 5 -8 In mice infected with N. brasiliensis and treated with DA-7218 (25 mg/kg), the number of lesions detected was lower than the number found in those treated with the same dose of linezolid, 5 and DA-7867 was active at lower concentrations (10 mg/kg) than linezolid when applied once a day in a BALB/c experimental model. 8 Nocardia can grow intracellularly in phagocytes and this makes treatment more difficult since antimicrobials need to penetrate deeply into fibrotic abscessed tissues. When drugs do not reach the bacteria, they can survive and produce new lesions. In order to predict which antimicrobial is useful to treat massive, chronic actinomycetomas, we consider it important to evaluate both its in vitro activity and the intracellular activity of the compound.
In the present study we standardized a model of N. brasiliensis infection using THP-1 macrophages to evaluate its intracellular replication in the presence of the oxazolidinones under test. Since this microorganism grows as clumps of filaments and the number of cfu does not represent the real quantity of bacteria (a nocardial clump can contain thousands of bacteria and produce only one colony), novel techniques have to be employed to determine nocardial growth. 
Materials and methods

Microorganisms
We utilized N. brasiliensis HUJEG-1, which was isolated from a thoracic case of mycetoma, and has been used extensively in immunological and susceptibility assays. 5, 9 It was kept in 10% skimmed milk at 2708C until use. 
Antimicrobial agents
Cell line
The human monocyte cell line THP-1 was maintained in RPMI 1640 medium (Gibco-BRL, Grand Island, NY, USA) supplemented with 10% fetal calf serum (FCS; Gibco-BRL) and 1 mM sodium pyruvate (Sigma, St Louis, MO, USA). In order to transform the cells into macrophages, the cells were subcultured four times without sodium pyruvate. The cell density was then determined in a haemocytometer and the cell suspension diluted as required in complete RPMI 1640 supplemented with 10% FCS and 6.25 ng/mL phorbol-12-myristate-13-acetate (Calbiochem Biosciences, Darmstadt, Germany) to obtain a density of 4Â10 5 cells/mL. A 1 mL aliquot of the cell suspension was seeded into each well of 24-well microplates (Costar Corning, Daly City, CA, USA) and cell cultures were washed twice with RPMI 1640 every 48 h for no longer than 4 days.
Preparation of the nocardial unicellular suspension N. brasiliensis HUJEG-1 was cultured on Sabouraud agar (Difco Laboratories, Detroit, MI, USA) for 1 week, and then subcultured in brain heart infusion (BHI; Difco Laboratories) at 378C in a shaker (New Brunswick Scientific C24, Edison, NJ, USA) at 110 rpm for 72 h. The bacterial mass was then separated by centrifugation (Eppendorf 5810R, Hamburg, Germany), and washed four times with saline solution. After grinding in an Evelham-Potter device (Fisher Scientific, Pittsburgh, PA, USA) the suspension was centrifuged twice at 100 g, the supernatant constituting the unicellular suspension. The bacterial concentration was quantified by agar plating on BHI with 5% sheep blood, and the suspension kept in 20% glycerin at 2708C until use. In order to determine the effect of mechanical grinding on bacterial viability, a drop of the suspension was stained with propidium iodide (live/dead Baclight kit of Invitrogen, Carlsbad, CA, USA).
Standardization of the macrophage infection
Tissue culture plates containing macrophages (THP-1 cell line) were infected with a nocardial suspension in RPMI 1640 with 10% FCS at bacteria/macrophage ratios of 1:1 and 3:1. After 1 h of incubation at 378C in 5% CO 2 (Nuaire NU-4750, Plymouth, MN, USA) the suspension was replaced with fresh medium. Bacteria were quantified from the supernatant and the macrophage monolayer at 3, 6, 12, 24 and 48 h by agar plating onto BHI and by the Alamar Blue method described below. Four-cell slide chambers (Lab-Tek II, Chamber Slide System, Nunc, Fisher Scientific, Pittsburgh, PA, USA) with the same macrophage densities and infection ratios were utilized for microscopic observation and, at the same time points, slides were stained with the Kinyoun method.
Quantification of nocardial growth by the Alamar Blue fluorometric method
A calibration curve was prepared by placing 0.6, 0.8, 1, 1.2, 1.4, 1.6, 1.8 and 2Â10
6 cfu of the unicellular suspension of N. brasiliensis HUJEG-1 in 1.5 mL Eppendorf tubes (Fisher Scientific), centrifuging at 10000 rpm for 10 min and discarding the supernatant. A 1 mL aliquot of Alamar Blue (Trek Diagnostics Systems, Cleveland, OH, USA), diluted 1:9 in Luria broth medium (Sigma), was added and the tubes incubated at 378C for 24 h with agitation. The tubes were centrifuged again and 200 mL of supernatant was collected into microplate wells and the fluorescence determined in a Multi-Detection Microplate Reader (Synergy HT, Biotek Instruments, Winooski, VT, USA) with Gen5 software at an excitation wavelength of 530 nm and an emission wavelength of 590 nm.
Determination of the intracellular activity of the oxazolidinones
A 3:1 multiplicity of infection (MOI) was chosen to determine the effect of antimicrobials on the nocardial intracellular growth. Two hours after infecting the monolayer, the medium was discarded and the monolayer washed twice with warm PBS, pH 7.4. The antimicrobials were added at 0.25Â, 1Â, 4Â and 16Â the MIC of each compound in RPMI 1640 with 10% FCS and incubated for a further 6 h at 378C in 5% CO 2 . After this time, most of the macrophages were infected with nocardial cells. The culture medium was discarded and 1 mL of cold distilled water was added and incubated for 15 min. In order to release the intracellular bacteria the monolayer was destroyed by pipetting back and forth several times and the suspension was collected in 1.5 mL Eppendorf tubes. Nocardial growth was quantified by the Alamar Blue method described above.
Statistical analysis
Potential differences among the groups against a control without oxazolidinones was established by Kruskal-Wallis analysis of variance (ANOVA), Dunnett's two-sided multiple comparison test with control and Dunnett's simultaneous confidence intervals for treatment versus control.
Results
Preparation of the unicellular suspension
Nocardia normally grow as a mass of filaments. By grinding the bacterial mass and centrifuging at 100 g we obtained a suspension composed of short filaments and individual bacteria (Figure 1 ). When staining with propidium iodide we observed a viability of .99% (not shown).
Growth of N. brasiliensis HUJEG-1 within the THP-1 monolayer
The analysis of bacterial growth on the monolayer cells in relation to the post-infection time showed that, after 1 h, only one-tenth of the inoculum remained associated with the macrophages, either attached to or engulfed by the phagocytes. When we observed the Kinyoun-stained slides of the infected macrophage monolayers, at 1 h there were many infected phagocytes with scarce short or unicellular fragments of bacteria in their cytoplasm (Figure 2a) . Six hours after infection, the phagocytes were full of Nocardia cells with a few clusters of filaments growing outside them (Figure 2b ). Twelve hours after infection, there were abundant giant microcolonies of Nocardia surrounded by clear areas of devastation of the macrophage monolayer. Macrophages were rounded and accumulated around the nocardial growth. They fused to produce binuclear or multinuclear cells (Figure 2c and f ) . Destruction of the monolayer was more evident after 24 h, with abundant Nocardia microcolonies intensely stained with fuchsine (Figure 2d) . At 48 h, the monolayer was almost completely destroyed, with scanty macrophages found among the nocardial microcolonies (Figure 2e) .
As the amount of Nocardia observed under the microscope did not correlate with the viable count, we measured the bacterial load by determining the reduction of Alamar Blue. In Figure 3 (left-hand graph) we show a standard curve made with several known amounts of bacteria from a cellular suspension. Using this method we were able to measure between 6Â10 5 and 1.8Â10 6 cfu. Beyond these ranges resolution was poor. When monitoring nocardial growth in the macrophage monolayer we observed a slight increase in the first 6 h; after this point, bacteria started to grow exponentially and, after 12 h, reached !1.8Â10 6 -approximately the upper limit of the technique (Figure 3, right-hand graph) . In the supernatant, we always had high concentrations of bacteria produced by the rupture of macrophages, and extracellular growth was evident (Figure 3 , right-hand graph).
For determination of the intracellular effect of the drugs, we selected 6 h of incubation with the compounds since at this time there was a large number of intracellular bacteria and the monolayer was still undamaged.
Effect of tested oxazolidinones on the nocardial growth
As seen in Figure 4 , linezolid shows a dose-dependent activity with statistical significance for all concentrations.
The experimental oxazolidinones, DA-7157 and DA-7218, also showed a remarkable activity, which was statistically significant for all concentrations compared with both control and linezolid (P ¼ 0.003).
Discussion
There are few studies on the growth of Nocardia inside macrophages, most of them performed with Nocardia asteroides type 6 (now Nocardia cyriacigeorgica). Beaman and Smathers 11, 12 used rabbit alveolar macrophages to study infection with strains of N. asteroides and described how the macrophage response was related to the virulence of the organism, the highly virulent strain being able to induce a dramatic macrophagic response that sequentially resulted in the formation of cellular aggregates, the appearance of round cells and multinucleated giant cells, and the subsequent destruction of the monolayer with the production of nocardial clumps floating in the medium-similar findings to those in the present study with N. brasiliensis using an MOI of 3:1. Traditionally, it has been considered that the species belonging to the formerly N. asteroides complex are less virulent than N. brasiliensis since they mainly cause diseases in immunosuppressed patients; however, it seems that the innate defence mechanisms have a similar behaviour against both species.
Beaman and Smathers 11 also noticed the limitations of quantification using viable counting since the floating clumps gave rise to one colony only. As we wanted to quantify the effect of the oxazolidinones on nocardial growth, a respirometric assay was developed based on a previously published study for Staphylococcus aureus.
13 Alamar Blue has the property to change the wavelength of fluorescence once it is reduced. When we quantified nocardial growth using known quantities of a unicellular suspension the method could determine up to 1.8Â10 6 cfu. Actinomycetoma is a tumour-like lesion with multiple abscesses and fistulae. The aetiological agents are found as microcolonies, although smaller amounts are found as intracellular living microorganisms. There are few successful therapeutic schemes to treat this condition. This may be due to the fact that, in vitro, few antibiotics can achieve optimal tissue concentrations or lack the ability to kill both intracellular and extracellular bacteria.
Oxazolidinones have been effective in vitro; DA-7867 seemed very promising since MIC values were lower than those of linezolid (0.03 mg/L compared with 2 mg/L for the isolate used in the animal experiments); 6 however, this potency was not observed in the murine model. In contrast, DA-7157 showed a better effect, inhibiting the production of extensive lesions, and most of the animals were completely cured. 5 With linezolid we observed a more modest effect. This may be related to the intracellular activity of these compounds, since DA-7157 is more active than linezolid.
Trius Therapeutics (San Diego, CA, USA) has acquired the rights over DA-7157 (TR-701) and DA-7218 (TR-700) from Dong-A Pharmaceutical Company and ran several tests including pharmacokinetics in humans. TR-700 at 200 and 400 mg orally produces plasma levels of .1 mg/L (the MIC 90 value for N. brasiliensis isolates) sustained for 10 h. 14 Since it has been observed that DA-7157 is 4-to 8-fold more potent in vivo against S. aureus 15 it should be possible to use lower doses (200 mg) every 12 h in order to avoid or minimize side effects, whilst still maintaining its antibacterial activity. The excellent intracellular antimicrobial activity detected suggests that these compounds could be very effective in the treatment of actinomycetoma. However, more studies are needed both in vitro and in vivo, including clinical trials, to confirm this issue. The measurements were made in triplicate; each point represents the mean of the assays and error bars represent the standard deviations. There were significant differences at all concentrations (P ¼0.003).
